<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05072158</url>
  </required_header>
  <id_info>
    <org_study_id>21-196</org_study_id>
    <nct_id>NCT05072158</nct_id>
  </id_info>
  <brief_title>Pelvic Floor Disorders Among Sexual Minoritized Women</brief_title>
  <acronym>PRIDE</acronym>
  <official_title>Pelvic Floor Disorders Among Sexual Minoritized Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Albany Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to perform cognitive interviews to assess how pelvic floor disorders&#xD;
      impact sexual functioning in women who have sex with women (WSW). As a secondary objective&#xD;
      there will be cognitive interviews to assess perceptions of sexual function questionnaires&#xD;
      such as Female Sexual Function Index (FSFI) and Pelvic Organ Prolapse/Urinary Incontinence&#xD;
      Sexual Questionnaire-IUGA Revised (PISQ-IR) in WSW.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is a paucity of data regarding care of women who have sex with women (WSW). While some&#xD;
      cohort studies are being performed in general gynecology, no studies document the reasons as&#xD;
      to why WSW seek urogynecological care, or how pelvic floor disorders (PFDs) affect sexual&#xD;
      function in this population. Another detrimental gap in current knowledge and a barrier to&#xD;
      care for WSW is the lack of understanding of what would drive WSW to seek care, if there are&#xD;
      special considerations for care, or if the commonly used condition specific questionnaires&#xD;
      adequately reflect their concerns. The Investigators aim to perform qualitative interviews to&#xD;
      understand how PFDs affect sexual function, and if commonly utilized sexual function&#xD;
      questionnaires are inclusive to WSW.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 14, 2021</start_date>
  <completion_date type="Actual">June 30, 2022</completion_date>
  <primary_completion_date type="Actual">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Qualitative impact of pelvic floor disorders on sexual function</measure>
    <time_frame>6 months</time_frame>
    <description>We will assess the impact of pelvic floor disorders with qualitative analysis and informational interviews</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Qualitative inclusivity of sexual function questionnaires</measure>
    <time_frame>6 months</time_frame>
    <description>We will examine this with guided focus groups</description>
  </secondary_outcome>
  <enrollment type="Actual">18</enrollment>
  <condition>Sexual Function Disturbances</condition>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Urinary Incontinence</condition>
  <condition>Fecal Incontinence</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>None, this is an observational study</intervention_name>
    <description>This is a qualitative study, we will be asking for patient experiences with PFDs and the impact on their sexual function.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        New patients over the age of 18 who present to urogynecology office or contact the research&#xD;
        team with interest in participating in the study who self-identify as women who have sex&#xD;
        with women. This may include but is not limited to: lesbian and bisexual women.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  WSW who have a PFD (pelvic organ prolapse, urinary incontinence, fecal incontinence)&#xD;
&#xD;
          -  Age &gt;18&#xD;
&#xD;
          -  Able to provide consent&#xD;
&#xD;
          -  Able to read/write in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  WSW who have not been sexually active in the past 6 months&#xD;
&#xD;
          -  Incarcerated patients&#xD;
&#xD;
          -  Pregnant or lactating patients&#xD;
&#xD;
          -  Unable to consent with study procedures or guided discussions&#xD;
&#xD;
          -  Unable to speak English&#xD;
&#xD;
          -  No sexual activity in the past 6 months&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>This trial is open only to wmen</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sierra Jansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>August 18, 2021</study_first_submitted>
  <study_first_submitted_qc>September 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2021</study_first_posted>
  <last_update_submitted>November 2, 2022</last_update_submitted>
  <last_update_submitted_qc>November 2, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Pelvic Floor Disorders</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

